Spotting Winners: Okta (NASDAQ:OKTA) And Cybersecurity Stocks In Q3

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the cybersecurity stocks, including Okta (NASDAQ:OKTA) ...

‘Monday Night Football’: How to Stream the Eagles vs. Chargers Game Online for Free

If you’re in the area and watch to catch the Eagles vs. Chargers game live, there are last-minute tickets available online ...

Why scammers open bank accounts in your name

Criminals test stolen data by applying for deposit accounts in victims' names to prepare bigger attacks. Learn why banks won't share fraud details.
San Mateo Daily Journal

Golden Globes enter the world of podcasts and tread carefully, avoiding controversy

The Golden Globes have introduced a best podcast category that's likely to spark conversations. On Monday, the Globes announced six nominees, including “Armchair Expert” and “SmartLess.” They represen ...
techUKOpinion

From property to finance: why the UK is ready for digital ID

Following the UK Government’s announcement on the introduction of mandatory digital ID on 26 September, techUK has published ...

AI Might Be Coming for Your Job. There’s a Proven Way to Fight Back.

More middle-age and older Americans are becoming entrepreneurs and seizing control of their careers. The leap can be ...

10 Things In Your Home That Might Be Interfering With Your Wi-Fi

Transmitting information through the air is no mean technological feat, yet troubleshooting Wi-Fi in your home may not be as ...

Professor Sarfaraz K. Niazi Files Landmark Citizen Petition Urging the FDA to Modernize Biosimilar Approval Pathways and Transform Global Access to Biological Medicines

Professor Sarfaraz K. Niazi, Ph.D., a leading authority in pharmaceutical sciences and internationally recognized biosimilars expert, has filed a major Citizen Petition with the U.S. Food and Drug ...